Revelation Biosciences, Inc.
REVB
$0.90
-$0.04-4.70%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 94.29% | -57.15% | -74.54% | -45.80% | -53.26% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.18% | 47.97% | 210.57% | -21.25% | -22.80% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 92.71% | -56.06% | -73.14% | -45.95% | -52.93% |
|
|
|||||
| Total Current Assets | 92.71% | -56.06% | -73.14% | -45.95% | -52.93% |
| Net Property, Plant & Equipment | -70.57% | -50.28% | -45.64% | -13.52% | 13.88% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 90.74% | -56.03% | -72.99% | -45.78% | -52.60% |
|
|
|||||
| Total Accounts Payable | -66.90% | -35.31% | -62.83% | -42.38% | 148.75% |
| Total Accrued Expenses | -12.31% | -91.25% | -25.26% | -2.14% | -8.57% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -95.83% | -99.94% | -99.97% | -99.93% | -99.85% |
| Total Other Current Liabilities | -95.83% | -99.94% | -99.97% | -99.93% | -99.85% |
| Total Current Liabilities | -54.40% | -85.90% | -79.16% | -65.61% | -24.69% |
|
|
|||||
| Total Current Liabilities | -54.40% | -85.90% | -79.16% | -65.61% | -24.69% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -54.40% | -85.90% | -79.16% | -65.61% | -24.69% |
|
|
|||||
| Common Stock & APIC | 39.70% | 29.59% | 20.77% | 40.79% | 29.21% |
| Retained Earnings | -20.96% | -23.16% | -51.19% | -59.05% | -66.69% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 311.50% | 235.48% | -69.59% | -29.17% | -69.68% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 311.50% | 235.48% | -69.59% | -29.17% | -69.68% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 311.50% | 235.48% | -69.59% | -29.17% | -69.68% |
|
|
|||||